Abstract
In a consecutive prospective series of 186 Swedish persons with the diagnosis of non-ulcer dyspepsia 71.5% were found to have gastritis and/or bulbar duodenitis in endoscopic biopsies. Gastroduodenitis was associated with campylobacter pylori (CP) in 83.5% of the cases. The double therapeutic approach using an antibiotic and a preparation containing bismuth in an uncontrolled therapeutic pilot trial resulted in improvement of the histological picture, disappearance of CP and amelioration of symptoms. It is concluded that CP-infection plays a central role in the pathogenesis of gastroduodenitis associated NUD.
MeSH terms
-
Adult
-
Aluminum Hydroxide / therapeutic use
-
Anti-Ulcer Agents / therapeutic use
-
Bismuth / therapeutic use
-
Campylobacter / isolation & purification
-
Campylobacter Infections / drug therapy
-
Campylobacter Infections / epidemiology*
-
Drug Combinations / therapeutic use
-
Dyspepsia / drug therapy
-
Dyspepsia / epidemiology*
-
Dyspepsia / etiology
-
Erythromycin / therapeutic use
-
Female
-
Glycyrrhiza
-
Humans
-
Magnesium Hydroxide
-
Male
-
Plant Extracts / therapeutic use
-
Prevalence
-
Prospective Studies
-
Sodium Bicarbonate
-
Sweden / epidemiology
Substances
-
Anti-Ulcer Agents
-
Drug Combinations
-
Plant Extracts
-
aluminum hydroxide, bismuth subnitrate, deglycyrrhizinised liquorice, magnesium carbonate, sodium bicarbonate drug combination
-
Aluminum Hydroxide
-
Erythromycin
-
Sodium Bicarbonate
-
Magnesium Hydroxide
-
Bismuth